Dendreon (DNDN) Falls On Rumors of Unexpected FDA Panel On Provenge

March 2, 2010 8:23 AM EST Send to a Friend
Shares of Dendreon Corp. (Nasdaq: DNDN) are seeing pressure this morning, which could be related to a report that the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login